服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-TNFRSF5/CD40 mAbs [Iscalimab Biosimilar] (MABL-4818) | MABL-4818 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ADAMTSL5;ALB mAbs [Isecarosmab Biosimilar] (MABL-4819) | MABL-4819 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A mAbs [Ispectamab Biosimilar] (MABL-4820) | MABL-4820 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IGF1R/CD221;ERBB3/HER3 mAbs [Istiratumab Biosimilar] (MABL-4821) | MABL-4821 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Lambda |
| Anti-MICA&MICB mAbs [Isuventatug Biosimilar] (MABL-4822) | MABL-4822 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274;IAP/CD47 mAbs [Itanistomig Biosimilar] (MABL-4823) | MABL-4823 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-IL33 mAbs [Itepekimab Biosimilar] (MABL-4824) | MABL-4824 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD6 mAbs [Itolizumab Biosimilar] (MABL-4825) | MABL-4825 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD37;CD37 mAbs [Ivicentamab Biosimilar] (MABL-4826) | MABL-4826 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-VEGFA;PDCD1/CD279/PD1 mAbs [Ivonescimab Biosimilar] (MABL-4827) | MABL-4827 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa;Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Ivuxolimab Biosimilar] (MABL-4828) | MABL-4828 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL17A mAbs [Ixekizumab Biosimilar] (MABL-4829) | MABL-4829 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CLDN6 mAbs [Ixotatug Biosimilar] (MABL-4830) | MABL-4830 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IFNG mAbs [Indematug Biosimilar] (MABL-4803) | MABL-4803 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-SNCA/PARK1/PARK4 mAbs [Indenebart Biosimilar] (MABL-4804) | MABL-4804 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-GUCY2C mAbs [Indusatumab Biosimilar] (MABL-4805) | MABL-4805 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD19 mAbs [Inebilizumab Biosimilar] (MABL-4806) | MABL-4806 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD40;MSLN mAbs [Inezetamab Biosimilar] (MABL-4807) | MABL-4807 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Lambda;Kappa |
| Anti-TNF/TNFA mAbs [Infliximab Biosimilar] (MABL-4808) | MABL-4808 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;KLRK1/NKG2D/CD314 mAbs [Ingitamig Biosimilar] (MABL-4809) | MABL-4809 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn